Position in NVS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$347,649,529
+$39,590,320 QoQ
Shares Held
2,275,938
+1.9% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 92%
None 8%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $11,353,030,401 across 14 Drug Manufacturers - General names. NVS ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,347,394 | $3,998,602,577 | |
| 2 | AZN |
Astrazeneca PLC
|
11,949,424 | $2,356,665,399 | |
| 3 | JNJ |
Johnson & Johnson
|
7,872,478 | $1,924,348,519 | |
| 4 | ABBV |
AbbVie Inc.
|
6,931,036 | $1,507,431,018 | |
| 5 | AMGN |
Amgen Inc
|
1,107,159 | $389,553,892 | |
| 6 | NVS |
Novartis AG
This page
|
2,275,938 | $347,649,529 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,880,199 | $346,459,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,972,639 | $274,926,696 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $347,649,529 | 2,275,938 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $308,059,209 | 2,234,418 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $265,293,421 | 2,068,726 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $263,659,249 | 2,178,822 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $249,258,242 | 2,235,901 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $229,507,872 | 2,358,523 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $292,364,851 | 2,541,861 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $271,357,277 | 2,548,913 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $248,473,059 | 2,568,728 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $257,747,430 | 2,552,713 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $258,004,962 | 2,532,937 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $262,493,751 | 2,601,266 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $332,192,036 | 3,610,783 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $356,828,340 | 3,933,293 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $253,817,912 | 3,339,270 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $269,590,176 | 3,189,284 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $296,672,658 | 3,380,885 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $311,321,387 | 3,559,179 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $325,935,580 | 3,985,517 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $386,735,977 | 4,238,667 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $391,615,080 | 4,581,365 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $440,950,422 | 4,669,601 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $403,468,920 | 4,639,707 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $409,419,176 | 4,687,648 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $367,665,409 | 4,459,253 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||